Why Your Peptide Comes in a Vial, Not a Pill

Most therapeutic peptides reach about one to two percent oral bioavailability at best. Here is what happens to a peptide you swallow, what it took to make one work as a tablet, and why route of administration should follow the evidence.

One of the most common questions we get is simple: why do peptides have to be injected? It’s a fair question. Nobody looks forward to a subcutaneous injection, and a pill would be easier.

The answer isn’t convention or convenience for the pharmacy. It’s pharmacology, and it’s the same reason AJ Peptide won’t offer certain products that are easy to find elsewhere.

Your digestive system is built to destroy peptides

A peptide is a short chain of amino acids joined by peptide bonds. Your digestive tract exists to break those same bonds, because that’s how you get amino acids from the protein you eat.

A peptide swallowed as a pill runs a gauntlet. In the stomach, acid denatures it and pepsin starts cutting the chain. In the small intestine, pancreatic enzymes such as trypsin, chymotrypsin, elastase and carboxypeptidases keep cutting, and more peptidases line the intestinal wall itself. Any intact molecule that survives still has to cross the intestinal lining, and most therapeutic peptides are too large and too polar to pass through easily. Whatever gets through then goes to the liver for first-pass metabolism before it reaches general circulation.¹

The result is that most therapeutic peptides have an oral bioavailability of roughly one to two percent at best, and often less. Nearly all of what you swallow never reaches the bloodstream intact.

Oral semaglutide shows how hard this is

The pharmaceutical industry has made an oral peptide work, and the example shows how much it takes.

Oral semaglutide is co-formulated with an absorption enhancer called SNAC. SNAC briefly raises the pH right around the tablet in the stomach, which protects the semaglutide from pepsin and helps it cross the stomach lining.² Even with this engineering, oral semaglutide’s bioavailability is under one percent, compared with roughly 89 percent for the subcutaneous injection.³⁴

To make up the difference, the oral product is dosed daily, at milligram amounts far larger than the weekly injectable dose. It also comes with strict rules: take it on an empty stomach with only a small sip of water, and wait before eating.³ The formulation took years of development and a proprietary delivery technology, and it still delivers only a small fraction of the drug.

Why subcutaneous injection works

A subcutaneous injection puts the peptide into the fatty tissue just under the skin. From there it absorbs into the bloodstream without ever facing stomach acid, digestive enzymes or first-pass metabolism in the liver. For most therapeutic peptides, it’s the most reliable and best-documented way to get the molecule where it needs to go.

That’s why the FDA-approved peptide drugs you’ve heard of, including semaglutide, tirzepatide, tesamorelin and insulin, are overwhelmingly injectables.

The AJ Peptide standard: route follows the evidence

We evaluate every product we carry and offer only the route of administration best supported by the evidence. If the pharmacokinetic data doesn’t support a route, we don’t offer it, even when other companies do.

Sermorelin is a good example. Some providers sell it as a capsule, a sublingual, and an injectable. Sermorelin is a 29-amino-acid peptide, the active fragment of growth hormone–releasing hormone, and it’s the kind of molecule the digestive system breaks down efficiently.⁵ The tissue under the tongue mostly absorbs much smaller molecules. We are not aware of published pharmacokinetic data showing that oral or sublingual sermorelin reliably reaches the bloodstream in meaningful amounts. Sermorelin’s clinical history is built on injection.⁶

So we offer sermorelin as an injectable. Not because it’s the only form someone could sell, but because it’s the form the science supports.

AJ Peptide is LegitScript certified.